GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
37.95
+0.36 (0.96%)
At close: Mar 3, 2025, 4:00 PM
38.62
+0.67 (1.77%)
Pre-market: Mar 4, 2025, 6:01 AM EST
GSK Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for GSK stock has a target of 47, which predicts an increase of 23.85% from the current stock price of 37.95.
Analyst Consensus: Hold
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for GSK stock from 4 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 4 | 5 | 5 | 5 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +39.66% | Jul 2, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +23.85% | May 30, 2024 |
Financial Forecast
Revenue This Year
33.75B
from 31.38B
Increased by 7.57%
Revenue Next Year
35.51B
from 33.75B
Increased by 5.22%
EPS This Year
1.73
from 0.62
Increased by 177.72%
EPS Next Year
1.92
from 1.73
Increased by 11.35%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 35.1B | 38.4B | 41.6B | ||
| Avg | 33.8B | 35.5B | 36.8B | ||
| Low | 31.6B | 32.6B | 33.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 11.9% | 13.9% | 17.0% | ||
| Avg | 7.6% | 5.2% | 3.7% | ||
| Low | 0.6% | -3.4% | -6.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.89 | 2.18 | 2.50 | ||
| Avg | 1.73 | 1.92 | 2.06 | ||
| Low | 1.48 | 1.59 | 1.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 203.4% | 26.2% | 29.9% | ||
| Avg | 177.7% | 11.3% | 7.1% | ||
| Low | 138.0% | -8.1% | -11.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.